Guys, Frustration is understandable. I have been a keen critic...

Guys,

Frustration is understandable. I have been a keen critic of PR on here. But (finally) the guy has delivered a very specific, comprehensive and professional clarification of where the company is, to the market properly. Not some casual fireside chat of massive guidance delay or hyping of deals at the AGM to a few privileged (but now less wealthy) investors informally. Finally some firm clarification of where deals are at after four years of alluding to them.

Lots of recrimination towards @Mozzarc. He did take the time and effort to type a nice recap for everyone. At worse he was guilty of some rose tinted glasses in one area subsequently that ultimately PR is the guilty party of embellishing and pumping in the past - and plenty of investors other than Mozz fell victim to that. Thanks for your more considered insights over the years Mozz.

If people have not listened to the presentation in full (we are all busy)....do so. The language and details are as specific as it can be and repeated again and again. Frankly if PAR get clearance from the FDA and a commercial deal did not emerge, I think some people's wish of his ousting from both CEO and Chair role would be quickly fullfilled by ASIC.

He reiterates several times that commercial deal agreements with interested parties from "China, South america and the United States are well advanced" and those parties are clearly waiting for FDA clearance before the "finalisation of commercialisation disuccions....at the moment companies are waiting for clearance before they make their decisions."

PR has a lot to make up to investors, but here at least pretty thorough and specific clarification to ALL mkt participants in a formal setting that would see him slaughtered professionally and possibly legally if it failed to emerge in some form.

Seems like some (selling) investors snatching defeat from the jaws of a likely (and oh so bloody long coming) victory here and at least some non-dilutive funding from commercial partnership promises finally on the brink of likelihood on FDA clearance - that from the few tidying up detail questions since their April response, seems likely on balance - after four years of alluding to by PR, doing what a few too many ASX CEO's do unpunished; pumping their stock.